This report uses RAND's COMPARE microsimulation model to estimate the effects of a 1332 waiver application from the state of Iowa. The waiver is designed to stabilize Iowa's Affordable Care Act individual market through a series of modifications. We estimate that the application would increase the federal deficit, but would decrease federal spending per enrollee on the ACA-compliant market.
The Effects of Iowa's Proposed Stopgap Measure on Health Insurance Costs and Coverage
Download eBook for Free
|PDF file||0.3 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
- What would the effects of the Iowa Stopgap Measure be on healthcare costs and coverage?
- Does the Iowa Stopgap Measure (designed to stabilize Iowa's Affordable Care Act–compliant healthcare market) meet 1332 State Innovation Waiver criteria?
On August 21, 2017, Iowa submitted a 1332 State Innovation Waiver application, known as the Iowa Stopgap Measure (ISM), to the U.S Treasury Department and the U.S. Department of Health and Human Services. The ISM was designed to stabilize Iowa's Affordable Care Act (ACA)–compliant individual market through a series of modifications: (1) a requirement that all insurers in the individual market offer a single standard plan, similar to the ACA's silver plan; (2) elimination of CSR subsidies for those with incomes between 200 and 250 percent of the federal poverty level (FPL); (3) a new premium tax credit structure (tax credits would vary by age and income and would be extended to individual market enrollees with incomes above 400 percent of the FPL); and (4) federally funded reinsurance on all annual individual market claims above $100,000. We found that the ISM is likely to lower premiums, decrease the number of uninsured, and decrease average health care spending for all groups on the ACA-compliant health insurance market. We estimate that ISM is likely to increase the federal deficit, but that the per-enrollee cost on the ACA-compliant market would decrease. We estimate that all groups with incomes over 200 percent of FPL on the ACA-compliant market could be at risk of foregoing necessary care, as they lose access to higher actuarial value plans. A reinsurance-only program, without the additional ISM features, could insure nearly as many people with no adverse deficit impact, assuming that reinsurance stimulates competition.
- The Iowa Stopgap Measure is likely to lower premiums, decrease the number of uninsured, and decrease average health care spending for most groups on the Affordable Care Act (ACA)–compliant health insurance market.
- The Iowa Stopgap Measure is also likely to increase the federal deficit, but the federal cost per enrollee on the ACA-compliant individual market would be lower than under current law.
- In addition, we estimate that enrollees with incomes over 200 percent of the federal poverty level on the ACA-compliant market could be at risk of foregoing necessary care, as they lose access to the higher actuarial value gold and platinum plans.
- For these reasons, we estimate that the Iowa Stopgap Measure would not meet the 1332 waiver criteria, which stipulate that proposed modifications must not increase the federal deficit.
- A reinsurance-only program, without the additional features of the Iowa Stopgap Measure, could insure nearly as many people as the Iowa Stopgap Measure with no adverse deficit impact, assuming that reinsurance is sufficient to stimulate competition in the Iowa insurance market.
This project is a RAND Venture. Funding was provided by the Paul O'Neill Alcoa Chair in Policy Analysis. The research was conducted within the RAND Health (NSRD) of the RAND Corporation.
This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.